| Literature DB >> 16757640 |
D R McClernon1, C Vavro, M St Clair.
Abstract
We evaluated the performance characteristics of a new, real-time nucleic acid sequence-based amplification (NASBA) assay that incorporates molecular beacon technology for detection of human immunodeficiency virus type 1 (HIV-1). The quantitative results were comparable to those obtained with three leading commercially available assays. The analytical sensitivity was 37 IU/ml. The NASBA assay detected clinically relevant recombinant viruses and all group M HIV-1 subtypes.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16757640 PMCID: PMC1489398 DOI: 10.1128/JCM.02187-05
Source DB: PubMed Journal: J Clin Microbiol ISSN: 0095-1137 Impact factor: 5.948